Q BioMed Inc.
QBIO
$0.00
$0.000.00%
OTC PK
| 02/28/2023 | 11/30/2022 | 08/31/2022 | 05/31/2022 | 02/28/2022 | |
|---|---|---|---|---|---|
| Net Income | 93.98% | 75.10% | 33.08% | 26.36% | 19.66% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | 6.41% | 126.13% | 499.79% | 802.51% | 725.92% |
| Total Other Non-Cash Items | -80.57% | -52.71% | -61.95% | -49.13% | -43.20% |
| Change in Net Operating Assets | 8.58% | 119.83% | 16.09% | 42.53% | 142.72% |
| Cash from Operations | 156.45% | 145.13% | 45.76% | 43.02% | 31.69% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -69.61% | -81.29% | 21.10% | 147.16% | 157.85% |
| Total Debt Repaid | -- | -- | 100.00% | -- | -- |
| Issuance of Common Stock | -100.00% | -90.10% | -92.50% | -92.50% | 138.77% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 21.43% | -- | -- | -- | -- |
| Cash from Financing | -76.18% | -79.69% | -25.22% | 12.23% | -33.36% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -27.96% | -276.15% | 98.87% | 90.36% | 2.49% |